Advertisement

Organisation › Details
Evonik Venture Capital GmbH (Corporate Venturing unit)
Since its inception in 2012, Evonik Venture Capital has realized 25 investments, both direct and fund investments. EVC has offices in Germany (Hanau/Essen), the U.S.A. (Parsippany) and China (Shanghai) and invests in young companies with innovative technology and high growth potential in the fields of Health & Care, Smart Materials, Animal Nutrition and Specialty Additives. Evonik Venture Capital’s team is made up of experienced investment managers that provide portfolio companies comprehensive support. The investment scope ranges from early stage to growth stage as well as follow-on financing with investment volume per portfolio company of up to €15 million. *
![]() |
Start | 2012-01-17 established |
Group | Evonik (Group) | |
![]() |
Industry | venture capital |
Industry 2 | specialty chemicals | |
![]() |
Person | Mohr, Bernhard (Evonik 201201– Head of Corporate Venturing) |
Person 2 | Herbeaux, Jean-Luc (Hovione 202204– CEO joined 5/20 as COO before Evonik Head of Health Care business) | |
![]() |
Region | Essen |
Country | Germany | |
City | n. a. Essen | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
Currency | EUR | |
Annual sales | 250,000,000 (capital under management (2019) 2019-02-12) | |
* Document for »About Section«: Evonik Industries AG. (2/12/19). "Press Release: Evonik more than Doubles Venture Capital to Accelerate Innovation. Evonik Has Launched Its Second Venture Capital Fund with a Volume of €150 Millionmillion". Essen. | ||
Record changed: 2024-12-29 |
Advertisement

More documents for Evonik (Group)
- [1] Leon-Nanodrugs GmbH. (12/5/24). "Press Release: Feasibility Study with Evonik Confirms Leon’s FR-JET Technology’s Performance in Advanced Nanoparticle Manufacturing for Drug Delivery". Munich, Planegg....
- [2] Abolis Biotechnologies SAS. (9/12/24). "Press Release: Abolis Biotechnologies Secures 35 Mio. Euro from International Consortium of Industrials and Funds". Èvry-Courcouronnes....
- [3] Evonik. (2/20/24). "Press Release: Evonik Partners with the University of Mainz to Commercialize a New Class of PEG Lipids for Nucleic Acid Delivery". Essen....
- [4] Evonik Industries AG. (6/2/22). "Press Release: Evonik Invests US$220 Million in Partnership with the U.S. Government to Build New Lipid Production Facility for mRNA-based therapies in the U.S.". Essen & Parsipanny, NJ....
- [5] Hovione. (2/25/22). "Press Release: Jean-Luc Herbeaux to Become Hovione CEO". Lisbon....
- [6] Evonik Industries AG. (8/2/21). "Press Release: Evonik Acquires German Biotech Company JeNaCell to Expand Biomaterials Portfolio for New Medical Device Markets". Essen....
- [7] Evonik Industries AG. (6/10/21). "Press Release: Evonik and Stanford University Sign Research Collaboration – Evonik to Market and Develop New Drug Delivery Platform for mRNA and Gene Therapy". Essen....
- [8] Evonik Industries AG. (2/11/21). "Press Release: Evonik Strengthens Strategic Partnership with BioNTech on COVID-19 Vaccine". Essen....
- [9] Evonik. (12/7/20). "Press Release: Fight Against COVID-19. Evonik Supplies Key Technology for Gene-based Drugs". Essen....
- [10] Evonik Industries AG. (3/17/20). "Press Release: Evonik Achieves Major Biotech Breakthrough with a New Animal-free and Fermentation-based Collagen Platform"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top